Bär & Karrer Advises Patrimonium on the Acquisition of a Majority Stake in the ROTH GROUPE
Bär & Karrer advised Swiss based Private Equity Fund Patrimonium on the acquisition of a majority stake in the ROTH GROUP, a Swiss provider of structural fire protection, technical insulation and coating solutions represented in all parts of Switzerland with 14 entities at 11 locations.
Bär & Karrer Advises the Shareholders on the Sale of NEPLAN to PSI
The shareholders of NEPLAN AG, a Swiss network planning software specialist, sold their shares to PSI group.
Bär & Karrer Advises Sovereign Capital Partners in the MBO of ACOLIN
Sovereign Capital Partners, the UK private equity Buy & Build specialist, has backed the management buy-out of ACOLIN, a leading provider of regulatory and cross-border fund distribution services, with offices in Zurich, Geneva, London, Frankfurt and Belgrade, among others. Sovereign’s support is an important step towards ACOLIN becoming a leading one-stop-shop service provider along the …
Continue reading “Bär & Karrer Advises Sovereign Capital Partners in the MBO of ACOLIN”
Bär & Karrer Advises Avaloq and Warburg Pincus on the Sale of Avaloq to NEC
Warburg Pincus, a leading global private equity firm, and other shareholders have sold their shares to NEC Corporation in an acquisition which valued Avlaoq at CHF 2.05 billion. Avaloq is an internationally leading FinTech company based in Switzerland.
Bär & Karrer Advises Fideuram – Intesa Sanpaolo Private Banking
Fideuram – Intesa Sanpaolo Private Banking, the private banking division of the Intesa Sanpaolo Group, and REYL & Cie SA have entered into a long-term strategic partnership, under which Fideuram will acquire a 69% interest in REYL and assign its Swiss subsidiary Intesa Sanpaolo Private Bank (Suisse) Morval SA to REYL.
Bär & Karrer Advises Vifor Pharma on the Sale of OM Pharma
Vifor Pharma, a global leader in iron deficiency, nephrology and cardio-renal therapies, has sold its OM Pharma business, which primarily focuses on therapies for respiratory and urinary tract infections and is active in the treatment of vascular diseases, to Optimus Holding Ltd., a company founded by Etienne Jornod together with long-standing Swiss entrepreneurs and the …
Continue reading “Bär & Karrer Advises Vifor Pharma on the Sale of OM Pharma”
Bär & Karrer Advised Novartis on the Placement of EUR 1,85 Billion Sustainability-Linked Bonds
Novartis Finance S.A., a subsidiary of Novartis AG, issued EUR 1,85 billion sustainability-linked bonds due 2028 with an interest rate of 0.000%. The bonds are the first of its kind in the healthcare industry and the first sustainability-linked bonds incorporating social targets, with bondholders entitled to receive a higher amount of interest if Novartis fails …
Bär & Karrer Advises PSP Swiss Property on the Acquisition of Three Attractive Commercial Buildings
PSP Swiss Property purchased three directly adjacent commercial buildings in the CBD of Geneva for CHF 295 million (plus transation costs). The three properties at Rue de la Confédération 2 (8,100 m2 rental space), Rue de la Corraterie 5/7 (5,400 m2) and Rue de la Cité 6 (2,100 m2) were acquired as of 22 September …
Kudun And Partners Appointed to Represent Various Creditors in Thai Airways Business Rehabilitation
Kudun and Partners has been officially appointed to represent a total of 87 savings co-operatives in their capacity as creditors of Thai Airways International Public Company Limited in Thailand’s largest-ever business rehabilitation proceeding to date, with debts estimated to be in excess of THB 352.49 billion (approximately USD 11.34 billion).
FG Münster: No capital gains tax due on furniture and fittings from sale of real estate
Furniture and fittings do not count towards capital gains from the sale of real estate. That was the verdict of the Finanzgericht (FG) Münster – the Fiscal Court of Münster – in a ruling form August 3, 2020 (Az.: 5 K 2493/18).